Login

2-Hydroxycinnamic acid

CAT:
804-HY-W012531-02
Size:
10 mM / 1 mL
Price:
Ask
For price, please contact [email protected]
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
2-Hydroxycinnamic acid - image 1

2-Hydroxycinnamic acid

  • CAS Number: 614-60-8
  • UNSPSC Description: 2-Hydroxycinnamic acid is a phenolic acid with antimicrobial and antioxidant properties. 2-Hydroxycinnamic acid has antimicrobial activity against Staphylococcus aureus and is not susceptible to drug resistance. 2-Hydroxycinnamic acid shows inhibitory effects on infection of HIV/SARS-CoV S pseudovirus with an IC50 of 0.3 mM. In addition, 2-Hydroxycinnamic acid has neuroprotective and antitumor activity[1][2][3][4].
  • Target Antigen: Bacterial; Endogenous Metabolite; HIV; SARS-CoV
  • Type: Natural Products
  • Related Pathways: Anti-infection;Metabolic Enzyme/Protease
  • Applications: COVID-19-anti-virus
  • Field of Research: Cancer; Infection; Inflammation/Immunology; Neurological Disease
  • Assay Protocol: https://www.medchemexpress.com/2-hydroxycinnamic-acid.html
  • Purity: 98.30
  • Solubility: DMSO : 100 mg/mL (ultrasonic)
  • Smiles: O=C(O)/C=C/C1=CC=CC=C1O
  • Molecular Weight: 164.16
  • References & Citations: [1]Tran Minh Ngoc, et al. A new coumarin and cytotoxic activities of constituents from Cinnamomum cassia. Nat Prod Commun. 2014 Apr;9(4):487-8.|[2]Min Zhuang, et al. Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection. Antiviral Res. 2009 Apr;82(1):73-81.|[3]Keman D, et al. Antibiotic-Resistant Staphylococcus aureus Does Not Develop Resistance to Vanillic Acid and 2-Hydroxycinnamic Acid after Continuous Exposure in Vitro. ACS Omega. 2019 Sep 10;4(13):15393-15400.|[4]Hao S, et al. Hydroxycinnamic Acid from Corncob and Its Structural Analogues Inhibit Aβ40 Fibrillation and Attenuate Aβ40-Induced Cytotoxicity. J Agric Food Chem. 2020 Aug 19;68(33):8788-8796.
  • Shipping Conditions: Room Temperature
  • Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
  • Clinical Information: No Development Reported